| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |